hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype

BACKGROUND: Both extracellular vesicles from mesenchymal stromal cell-derived human umbilical cords (hUC-EVs) and arsenic trioxides (ATOs) have been demonstrated to treat acute graft-versus-host disease (aGVHD) via immunomodulation. Apart from immunomodulation, hUC-EVs have a unique function of drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yan, Sun, Xueyan, Liu, Xiao, Qu, Qingyuan, Yang, Liping, Chen, Qi, Liu, Fengqi, Li, Yueying, Wang, Qianfei, Huang, Bo, Huang, Xiao-Hui, Zhang, Xiao-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306027/
https://www.ncbi.nlm.nih.gov/pubmed/35864538
http://dx.doi.org/10.1186/s13045-022-01315-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306027/
https://www.ncbi.nlm.nih.gov/pubmed/35864538
http://dx.doi.org/10.1186/s13045-022-01315-2

Ejemplares similares